Skip to content
PatentBrief

Inventor

Bruce L. Levine

Patents indexed

2

Year range

2016

Associated with

Years active

2016

Total patents

2

Most recent

2016

Frequent collaborator

Michael D. Kalos

Domains

biotechpharmaceuticalgene_editingoncology

Activity by decade

2010s
2

Patents

2

Career timeline

2 patents, in 2016

Dot size = forward citations

20162017

Hover or tap any dot to see the patent. Larger dots indicate more forward citations — a proxy for downstream influence.

US 9481728·2016·University of Pennsylvania Penn

How Genetically Modified T-Cells Fight CD19 Cancers

This patent describes how to create and use genetically modified human T cells that target and kill cancer cells expressing the CD19 protein, offering a new way to treat blood cancers.

US 9328156·2016·University of Pennsylvania Penn

How Genetically Modified T-Cells Attack Cancer

This patent describes how human T cells are genetically engineered to express a special receptor (CAR) that specifically targets and kills cancer cells, particularly those with the CD19 marker, offering a new way to treat cancer.

Patent monitoring

Get a weekly digest when new patents naming Bruce L. Levine are indexed.

Get alerts →